Ovoca Bio (CDI) (OVB) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 Nov 2025 07:00 AM
RNS
Change of Broker
30 Sep 2025 01:09 PM
RNS
Replacement Half Year Report
30 Sep 2025 07:00 AM
RNS
Half-year Report
26 Jun 2025 07:00 AM
RNS
Publication of 2024 Annual Report
05 Jun 2025 07:00 AM
RNS
Delisting from Euronext Growth Exchange
07 May 2025 07:30 AM
RNS
Suspension - Ovoca Bio plc
07 May 2025 07:00 AM
RNS
Proposed Acquisition, Disposal & Reverse Takeover
03 Mar 2025 02:00 PM
RNS
Management Changes
18 Dec 2024 06:00 PM
RNS
Result of AGM
18 Nov 2024 07:00 AM
RNS
Notice of AGM
11 Oct 2024 05:30 PM
RNS
Holding(s) in Company
09 Oct 2024 05:45 PM
RNS
Sale of Treasury Shares
25 Sep 2024 07:00 AM
RNS
Half-year Report
02 Sep 2024 02:30 PM
RNS
Consultancy Agreement
15 Jul 2024 07:00 AM
RNS
Directorate Change
15 Jul 2024 07:00 AM
RNS
Director/PDMR Shareholding
28 Jun 2024 07:00 AM
RNS
Annual Financial Report
23 Jan 2024 07:00 AM
RNS
Holding(s) in Company
01 Dec 2023 12:00 PM
RNS
Result of AGM
07 Nov 2023 09:15 AM
RNS
Notice of AGM
28 Sep 2023 07:00 AM
RNS
Interim Results
31 Aug 2023 07:00 AM
RNS
Summary Results of Phase II Study for Orenetide
30 Jun 2023 07:00 AM
RNS
Annual Financial Report
12 Jun 2023 07:00 AM
RNS
Update on Completion Timelines for Phase II Study
16 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
16 Mar 2023 02:05 PM
RNS
Second Price Monitoring Extn
16 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
16 Mar 2023 09:05 AM
RNS
Second Price Monitoring Extn
16 Mar 2023 09:00 AM
RNS
Price Monitoring Extension
08 Mar 2023 07:00 AM
RNS
Disposal of Russian Assets
14 Feb 2023 04:41 PM
RNS
Second Price Monitoring Extn
14 Feb 2023 04:35 PM
RNS
Price Monitoring Extension
14 Feb 2023 02:05 PM
RNS
Second Price Monitoring Extn
14 Feb 2023 02:00 PM
RNS
Price Monitoring Extension
13 Feb 2023 09:00 AM
RNS
Price Monitoring Extension
13 Jan 2023 11:05 AM
RNS
Second Price Monitoring Extn
13 Jan 2023 11:00 AM
RNS
Price Monitoring Extension
28 Oct 2022 07:00 AM
RNS
Result of AGM
06 Oct 2022 02:30 PM
RNS
Notice of AGM
30 Sep 2022 07:00 AM
RNS
Interim Results
29 Jul 2022 07:00 AM
RNS
Completion of Enrollment in Phase II Study
30 Jun 2022 07:00 AM
RNS
Annual Financial Report
07 Mar 2022 09:00 AM
RNS
Statement re Russian Business Operations
23 Feb 2022 04:41 PM
RNS
Second Price Monitoring Extn
23 Feb 2022 04:36 PM
RNS
Price Monitoring Extension
22 Feb 2022 03:30 PM
RNS
Russian Marketing Authorisation for Orenetide
31 Jan 2022 07:00 AM
RNS
Board Changes and Update
30 Dec 2021 07:00 AM
RNS
Directorate Change
04 Nov 2021 03:53 PM
RNS
Holding(s) in Company
04 Nov 2021 03:50 PM
RNS
Director/PDMR Shareholding

Ovoca Bio PLC is a biopharmaceutical company focused on women's health, specifically developing novel treatments for female sexual dysfunction. Their lead product, Orenetide (BP-101), is a synthetic peptide administered via nasal spray, designed to treat hypoactive sexual desire disorder in premenopausal women. The company is incorporated in Ireland and operates in Ireland, the UK, and Russia. It is listed in London under the ticker OVB.

OVB share price was suspended from AIM on 7 May 2025.

 

UK 100

Latest directors dealings